Cargando…
Association between Metformin Use and Risk of Lactic Acidosis or Elevated Lactate Concentration in Type 2 Diabetes
PURPOSE: Metformin can reduce diabetes-related complications and mortality. However, its use is limited because of potential lactic acidosis-associated adverse effects, particularly in renal impairment patients. We aimed to investigate the association of metformin use with lactic acidosis and hyperl...
Autores principales: | Lee, Eun Young, Hwang, Sena, Lee, Yong-ho, Lee, Seo Hee, Lee, Young Mi, Kang, Hua Pyong, Han, Eugene, Lee, Woonhyoung, Lee, Byung-Wan, Kang, Eun Seok, Cha, Bong Soo, Lee, Hyun Chul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Yonsei University College of Medicine
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5290010/ https://www.ncbi.nlm.nih.gov/pubmed/28120561 http://dx.doi.org/10.3349/ymj.2017.58.2.312 |
Ejemplares similares
-
Transient Blindness in a Patient with Severe Metformin-Associated Lactic Acidosis (MALA)
por: Jeon, Jae Wan, et al.
Publicado: (2019) -
Metformin-Associated Lactic Acidosis: Predisposing Factors and Outcome
por: Kim, Min Ju, et al.
Publicado: (2015) -
Metformin Restores Parkin-Mediated Mitophagy, Suppressed by Cytosolic p53
por: Song, Young Mi, et al.
Publicado: (2016) -
Ipragliflozin Additively Ameliorates Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Controlled with Metformin and Pioglitazone: A 24-Week Randomized Controlled Trial
por: Han, Eugene, et al.
Publicado: (2020) -
Sodium Glucose Cotransporter-2 Inhibitors as an Add-on Therapy to Metformin Plus Dipeptidyl Peptidase-4 Inhibitor in Patients with Type 2 Diabetes
por: Bae, Jaehyun, et al.
Publicado: (2022)